FDA Pauses Cialis Prescription-to-OTC Trial
The US Food and Drug Administration (FDA) has put a wrench in Sanofi’s efforts to transition its erection dysfunction medication [...]
Webinar: Accelerating patient recruitment in clinical trials post COVID-19 – June 8th
Patient recruitment is a make or break aspect of any clinical trial. The COVID-19 pandemic has upended the patient recruitment [...]
Whitepaper: Digital Transformation in Clinical Research
As the clinical research landscape increasingly becomes digitized, adopting new technologies is paramount for clinical research organizations. In a new [...]
PM Live Interview: Improving Drug Access with Data Analytics – Earlene Biggs, VP of Market Research and Analytics at ICON
Accurate and insightful market research is essential to successfully bring therapeutics from the drawing board to patients. In a new [...]
Reevaluating Clinical Trials with Technology
Data technology background. Big data visualization. Flow of data. Information code. Background in a matrix style. 4k rendering. [...]
Using Technology to Diversify Clinical Trials
Mirroring the shift towards widespread remote working arrangements, the COVID-19 pandemic triggered a push towards virtual and decentralized clinical trial [...]
What Holds Back Diversity in Clinical Trials?
Despite an industry-wide push for diversity, equity, and inclusion efforts, clinical trials still suffer from a lack of diversity. Patient [...]
Fierce Biotech Webinar: The ‘D’ in DCT stands for Decentralized
Decentralized trial (DCT) design has emerged in recent years and shaken up the clinical trial landscape. In an upcoming webinar [...]
Webinar: Accelerating Patient Recruitment in Clinical Trials Post COVID-19
Patient recruitment can make or break a clinical trial. Unfortunately, it is also one of the most difficult problems facing [...]
The Importance of Integrated Service Offerings in Biopharma
Smaller biotechs have pivoted in recent years from selling products early in the development cycle to holding onto their assets. [...]
Developing a Resilient Patient-Centered Clinical Supply Chain
As clinical trials grow in complexity, the need for resilient supply chains is increasingly apparent. The industry is responding by [...]
Bayer Backs Out of Atara CAR-T Partnership
Following a pause in a CAR-T cell mesothelioma therapy caused by a patient death, Bayer has pulled out of a [...]
Pfizer and Headlands Health Partner to Increase Clinical Trial Diversity
Clinical trial participants are often far less diverse than the populations they represent, as clinical trial sites are often located [...]
The Present and Future State of Clinical Trial Staffing
Clinical trial staffing is a growing market, with demand beginning to outstrip the supply of qualified clinical research associates (CRA’s). [...]
Lack of Funding and COVID Outbreaks Sank Chinese Drugmaker’s Alzheimer’s Phase III Trial
Green Valley Pharma has ended its Phase III clinical trial for its Alzheimer’s drug due to funding issues and new [...]
Real-World Data and the Benefits of External Control Arms
The expansion of real-world data (RWD) in regulatory decision-making, spurred on in the US by the 21st Century Cures Act, [...]
Positive Results Announced for Bristol Meyer Squibb’s Plaque Psoriasis Trial
Bristol Meyer Squib (BMS) has released promising two-year results for deucravacitinib, its psoriasis therapeutic. The results show the drug was [...]
Life Science Leader: 5 Trends to Watch
As clinical research begins to pivot back from a single-minded focus on COVID-19 therapeutics and vaccines, the life sciences field [...]
Conference: 4th Annual Cell Engager Summit – May 24-26 – Boston, MA
Research into T cell engagers (TCEs) is heating up, with over 100 preclinical projects and 65+ phase I and phase [...]
Gilead Partners with Dragonfly to Investigate Natural Killer Cell Therapeutics
Gilead has announced a $300 billion deal with Dragonfly Therapeutics to advance natural killer (NK) cell therapy for use in [...]
Abbvie Scraps Cystic Fibrosis Triplet Therapy
Abbvie announced that it is dropping its triplet therapy for cystic fibrosis (CF) after a disappointing interim analysis in a [...]
Speaking Opportunities at Pharma Clinical 2022
Pharma Clinical 2022, which takes place virtually from May 17th-19th, is looking to fill its remaining sponsorship roles. Sponsors will [...]
Roche’s Oral Breast Cancer Drug Disappoints in Phase II Study
The pharma manufacturer Roche has announced discouraging results for its oral breast cancer drug giredestrant. Results show that the drug [...]
Decentralized Clinical Trials and Real-World Evidence: 3-year Projections for Clinical Trials
Data technology background. Big data visualization. Flow of data. Information code. Background in a matrix style. 4k rendering. [...]
European Medical Agency: Clinical Trials Require Substantial Changes Due to War in Ukraine.
The invasion of Ukraine has greatly impacted clinical trials in Europe, as the country housed many clinical trial sites. Sponsors [...]